Tella Incorporation operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Tella Incorporation with three other
companies in this sector in Japan:
Human Metabolome Technologies Inc
sales of 914.18 million Japanese Yen [US$8.23 million]
SanBio Co Ltd
(949.54 million Japanese Yen [US$8.55 million]
of which 100%
was Commercial Physical Research), and
Gene Techno Science Co Ltd
(1.09 billion Japanese Yen [US$9.80 million]
Tella Incorporation reported sales of ¥957.64 million (US$8.62 million)
December of 2017.
decrease of 46.9%
versus 2016, when the company's sales were ¥1.80 billion.
Contributing to the drop in overall sales was the 55.9% decline
in Cell Therapy Support Business, from ¥994.76 million to ¥439.14 million.
There were also decreases in sales in
Cell Therapy Technology Development Busi (down 35.8% to ¥518.51 million)